|
NOP14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.27780000025446E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13339999607831E-08 |
| Normal-vs-Stage2 |
7.337700E-03 |
| Normal-vs-Stage3 |
2.782400E-03 |
| Normal-vs-Stage4 |
6.319400E-01 |
| Stage1-vs-Stage2 |
7.030800E-01 |
| Stage1-vs-Stage3 |
5.219400E-01 |
| Stage1-vs-Stage4 |
5.579700E-02 |
| Stage2-vs-Stage3 |
8.870200E-01 |
| Stage2-vs-Stage4 |
2.039200E-01 |
| Stage3-vs-Stage4 |
2.039400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.30110000054573E-07 |
| Normal-vs-AfricanAmerican |
4.64650000031597E-07 |
| Normal-vs-Asian |
9.726200E-01 |
| Caucasian-vs-AfricanAmerican |
3.485600E-01 |
| Caucasian-vs-Asian |
1.480430E-01 |
| AfricanAmerican-vs-Asian |
6.317600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76180003919058E-09 |
| Normal-vs-Female |
9.206300E-02 |
| Male-vs-Female |
2.575400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.215800E-04 |
| Normal-vs-Extreme_Weight |
8.41170466614471E-11 |
| Normal-vs-Obese |
1.593340E-04 |
| Normal-vs-Extreme_Obese |
1.384020E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.928300E-02 |
| Normal_Weight-vs-Obese |
8.645800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.039800E-01 |
| Extreme_Weight-vs-Obese |
2.461900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.646200E-01 |
| Obese-vs-Extreme_Obese |
4.148800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.919400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.13199999995928E-06 |
| Normal-vs-Age(61-80Yrs) |
1.70169999980097E-07 |
| Normal-vs-Age(81-100Yrs) |
2.400400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.114000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.299900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.915800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.974000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.257700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.703180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.11420009172048E-10 |
| Normal-VS-Type2 PRCC |
6.608400E-04 |
| Normal-VS-KIRP CIMP |
7.687600E-01 |
| Normal-VS-Unclassified PRCC |
1.057700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.174100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.172100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.205900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.289600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.874000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.194200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65659999995516E-06 |
| Normal-vs-N1 |
6.979400E-01 |
| Normal-vs-N2 |
9.750400E-01 |
| N0-vs-N1 |
8.332400E-02 |
| N0-vs-N2 |
1.242230E-01 |
| N1-vs-N2 |
9.020800E-01 |
|
|
